Medtronic recently received FDA approval for its MiniMed 780G system, which is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ glucose levels every five minutes. The news comes two years after Medtronic submitted the system for FDA approval and three years after the company began selling the product in Europe.
The company received a warning letter on Wednesday related to inadequate quality requirements at the headquarters for its diabetes business. It comes after Medtronic expanded a recall of its MiniMed 600 series insulin pumps.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Medtronic is expanding a recall of two of its MiniMed 600 series insulin pumps after reports found several had broken retainer rings cracked, resulting in insulin doses that were too high or too low.
The San Diego-based company has is in the midst of one of the most precipitous turnarounds in the medical device industry and is well positioned to grow alongside the expanding insulin pump market.
In a bid to expand into the larger, more lucrative type 2 diabetes market, the medical device maker offers a performance guarantee to payers and employers tied to its MiniMed 670G insulin pump system.
J&J, based in New Brunswick, New Jersey, sent a letter to patients last week from its Animas subsidiary acknowledging three security vulnerabilities first brought to the company's attention six months ago.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Bigfoot Biomedical is building an artificial pancreas, combining continuous glucose monitor tech with an insulin pump - and raising some capital to do so.
It looks like Valeritas, which is developing insulin pumps for Type 2 diabetes, is in the midst of raising another big round of cash. The New Jersey medical device company filed paperwork with the SEC indicating it’s raised about $22 million in a round that could go as high as $45 million. Valeritas has been ramping up […]